Contrast enhancement in 1p/19q-codeleted anaplastic oligodendrogliomas is associated with 9p loss, genomic instability, and angiogenic gene expression.
about
Mitotic index, microvascular proliferation, and necrosis define 3 groups of 1p/19q codeleted anaplastic oligodendrogliomas associated with different genomic alterations.Copy number variation analysis based on AluScan sequencesMassive interstitial copy-neutral loss-of-heterozygosity as evidence for cancer being a disease of the DNA-damage response.Contribution of 1p, 19q, 9p and 10q Automated Analysis by FISH to the Diagnosis and Prognosis of Oligodendroglial Tumors According to WHO 2016 Guidelines.Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial.Radiological features combined with IDH1 status for predicting the survival outcome of glioblastoma patients.Molecular imaging of 1p/19q deletion in oligodendroglial tumours with 11C-methionine positron emission tomographyImmunocytochemical markers of neuronal maturation in human diagnostic neuropathology.Molecular diagnostics: techniques and recommendations for 1p/19q assessment.Identifying the association between contrast enhancement pattern, surgical resection, and prognosis in anaplastic glioma patients.Patterns of Tumor Contrast Enhancement Predict the Prognosis of Anaplastic Gliomas with IDH1 Mutation.Regional specificity of 1p/19q co-deletion combined with radiological features for predicting the survival outcomes of anaplastic oligodendroglial tumor patients.Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX status.Predicting IDH mutation status in grade II gliomas using amide proton transfer-weighted (APTw) MRI.Detecting isocitrate dehydrogenase gene mutations in oligodendroglial tumors using diffusion tensor imaging metrics and their correlations with proliferation and microvascular density.Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion.Prediction of IDH1-Mutation and 1p/19q-Codeletion Status Using Preoperative MR Imaging Phenotypes in Lower Grade Gliomas.Association between molecular alterations and tumor location and MRI characteristics in anaplastic gliomas.Tumor cells with neuronal intermediate progenitor features define a subgroup of 1p/19q co-deleted anaplastic gliomas.MethCNA: a database for integrating genomic and epigenomic data in human cancer.Combination of diffusion tensor imaging and conventional MRI correlates with isocitrate dehydrogenase 1/2 mutations but not 1p/19q genotyping in oligodendroglial tumours.Imaging Markers of Isocitrate Dehydrogenase-1 Mutations in Gliomas.Impact of 9p deletion and p16, Cyclin D1, and Myc hyperexpression on the outcome of anaplastic oligodendrogliomas.Multi-faceted computational assessment of risk and progression in oligodendroglioma implicates NOTCH and PI3K pathwaysMolecular profiles of tumor contrast enhancement: A radiogenomic analysis in anaplastic gliomas
P2860
Q34062043-3829371E-6E57-46E4-A438-A6D6E41F3A09Q34754017-0A64CB07-B62E-47B8-B2FD-13708CCD1C81Q35712405-8B89E2C2-793C-4399-A5B3-E13973A382B7Q36234884-30FFCE41-FAB0-4ADE-A272-B3944A298870Q36618241-DE4DC503-1A6D-4A85-90C5-1C6FC06F9428Q36705913-2EE59246-E16A-437E-88F8-CC3463547CEAQ37235829-5D86F92C-52A0-4CA1-BB56-D44A61F41422Q38250190-69C7D44F-FE3C-45A9-B693-07C756806F4DQ38627124-215488E1-8F10-4096-9D8E-C471E25FD6C4Q40960183-28E03DB2-6999-466A-9CF5-01957C33815EQ41443549-12E7749F-FFA0-4D10-B268-DD03447D9DB6Q47325891-36170896-BC58-48A0-9173-4F2175C8DE32Q48035299-B3A3340F-7008-4CB9-85B5-F91CFFE6AFE9Q48117662-4504185E-73FA-4D4A-8174-1DC2D471A0CAQ48157881-B3B1AA4F-7DD6-47BD-99A7-4B0B0C678D35Q48166117-9355626C-D551-494F-AB9B-DC4B4057E831Q48331864-4F05A588-1B83-408B-A8F1-46DC6F4A41ECQ48401310-AC4CE12A-9AD5-4BC6-A0DF-1D413953659DQ48455154-8FD163D4-3035-4561-896B-8131275F8E85Q49639816-48685E53-8488-4AE8-913D-5FE20341F24DQ52148950-EEBCE434-7028-41A6-8E64-7C9443D6623EQ52151986-8B53F10E-AA15-4D5C-909B-FD4BB5EE2C54Q54123926-555D48A5-93B3-4BC4-9395-5D36C8F7F8E2Q58700004-2B612153-F859-4FAB-A03E-2C789A9FB785Q58772586-5BAAB243-00E1-4479-A2F5-C3309DE86E04
P2860
Contrast enhancement in 1p/19q-codeleted anaplastic oligodendrogliomas is associated with 9p loss, genomic instability, and angiogenic gene expression.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Contrast enhancement in 1p/19q ...... nd angiogenic gene expression.
@en
Contrast enhancement in 1p/19q ...... nd angiogenic gene expression.
@nl
type
label
Contrast enhancement in 1p/19q ...... nd angiogenic gene expression.
@en
Contrast enhancement in 1p/19q ...... nd angiogenic gene expression.
@nl
prefLabel
Contrast enhancement in 1p/19q ...... nd angiogenic gene expression.
@en
Contrast enhancement in 1p/19q ...... nd angiogenic gene expression.
@nl
P2093
P2860
P50
P356
P1433
P1476
Contrast enhancement in 1p/19q ...... nd angiogenic gene expression.
@en
P2093
Ahmed Idbaih
Carole Ramirez
Caroline Dehais
Catherine Carpentier
Elisabeth Moyal
Eric Letouzé
German Reyes-Botero
Hugues Loiseau
Jerome Honnorat
Marion Lahutte
P2860
P304
P356
10.1093/NEUONC/NOT235
P577
2013-12-18T00:00:00Z